Clal Insurance’s SPDR S&P Biotech ETF XBI Stock Holding History

Clal Insurance’s Portfolio XBI Stock Details XBI Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$35.5M	Buy	428,000 +174,000	+69%	+$14.4M	0.35%	59
2025 Q1	$20.6M	Sell	254,000 -280,000	-52%	-$22.7M	0.21%	64
2024 Q4	$48.1M	Sell	534,000 -896,000	-63%	-$80.7M	0.43%	48
2024 Q3	$141M	Buy	+1,430,000	New	+$141M	1.25%	23
2023 Q4	–	Sell	-357,015	Closed	-$26.1M	–	135
2023 Q3	$26.1M	Hold	357,015	–	–	0.36%	57
2023 Q2	$29.7M	Sell	357,015 -310,000	-46%	-$25.8M	0.36%	63
2023 Q1	$50.8M	Sell	667,015 -912,985	-58%	-$69.6M	0.76%	39
2022 Q4	$131M	Hold	1,580,000	–	–	1.97%	17
2022 Q3	$125M	Sell	1,580,000 -862,000	-35%	-$68.4M	1.72%	17
2022 Q2	$181M	Buy	2,442,000 +412,000	+20%	+$30.6M	2.41%	9
2022 Q1	$182M	Buy	2,030,000 +1,182,000	+139%	+$106M	1.93%	13
2021 Q4	$94.9M	Buy	848,000 +276,650	+48%	+$31M	1.03%	28
2021 Q3	$71.8M	Buy	571,350 +111,000	+24%	+$14M	0.82%	42
2021 Q2	$62.3M	Buy	460,350 +270,000	+142%	+$36.6M	0.71%	55
2021 Q1	$25.8M	Sell	190,350 -333,500	-64%	-$45.2M	0.3%	88
2020 Q4	$68.9M	Sell	523,850 -146,150	-22%	-$19.2M	0.94%	41
2020 Q3	$74.7M	Hold	670,000	–	–	1.26%	29
2020 Q2	$75M	Sell	670,000 -265,000	-28%	-$29.7M	1.49%	19
2020 Q1	$72.4M	Buy	935,000 +874,680	+1,450%	+$67.7M	1.81%	18
2019 Q4	$634K	Sell	60,320 -873,894	-94%	-$9.19M	0.68%	40
2019 Q3	$71.2M	Hold	934,214	–	–	1.73%	15
2019 Q2	$81.9M	Buy	934,214 +1,214	+0.1%	+$106K	1.88%	16
2019 Q1	$84.5M	Buy	933,000 +333,000	+56%	+$30.1M	2.07%	17
2018 Q4	$43.1M	Hold	600,000	–	–	1.12%	27
2018 Q3	$57.5M	Hold	600,000	–	–	1.53%	20
2018 Q2	$57.1M	Sell	600,000 -752,197	-56%	-$71.6M	1.48%	22
2018 Q1	$119M	Buy	+1,352,197	New	+$119M	3.15%	12
2017 Q1	–	Sell	-125,500	Closed	-$7.43M	–	79
2016 Q4	$7.43M	Hold	125,500	–	–	0.14%	41
2016 Q3	$8.32M	Buy	+125,500	New	+$8.32M	0.19%	49